Ignite Creation Date:
2025-12-25 @ 1:06 AM
Ignite Modification Date:
2026-03-08 @ 1:48 AM
Study NCT ID:
NCT03172793
Status:
COMPLETED
Last Update Posted:
2019-10-24
First Post:
2017-05-09
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Telavancin Pharmacokinetics in Cystic Fibrosis Patients
Sponsor:
Joseph L. Kuti, PharmD
Organization:
Organization Data
Organization:
Class:
OTHER
Study ID:
HHC-2017-0093
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR_INVESTIGATOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None
Collaborators
Collaborators
| Name | Class | View |
|---|---|---|
| None | UNKNOWN | View |